Sebastian Jugl wins an American Heart Association Career Development Award
The research assistant professor of pharmaceutical outcomes and policy investigates cardiovascular safety of medical cannabis.
Posted in
Faculty
Dr. Masoud Rouhizadeh elected a fellow of the American Medical Informatics Association
The assistant professor will mentor the next generation of interdisciplinary scientists.
Popular diabetes medications may protect against Alzheimer’s disease, UF researchers find
Dr. Serena Jingchuan Guo is the senior author of a study published in JAMA Neurology April 7.
UF researchers demonstrate GLP-1RAs’ potential to treat depression
A study led by Dr. Serena Jingchuan Guo may carry significant implications for older patients with diabetes.
UF Health researchers receive NIH R01 grant to develop social risk management tool for people living with dementia
A team of UF Health researchers led by Serena Jingchuan Guo, M.D. Ph.D., aims to reduce health inequities faced by people living with dementia.
Interdisciplinary team led by Dr. Rachel Reise wins UF Health Shands Board Quasi Endowment award
Reise's team aims to improve the quality of ambulatory preoperative internal medicine consultation and perioperative medication reconciliation at UF Health Shands hospitals.
Dr. Haesuk Park wins UF Health Shands Board Quasi Endowment to study barriers to PrEP care
Park is conducting a survey study of UF Health providers about barriers to PrEP care in UF Health outpatient clinics.
Dr. Serena Jingchuan Guo wins the UF Excellence Award for Assistant Professors
Serena Jingchuan Guo, an assistant professor in the UF College of Pharmacy department of pharmaceutical outcomes and policy, is a recipient of this year’s UF Excellence Award for Assistant Professors.
UF study uses machine learning to predict opioid use disorder treatment interruptions
University of Florida researchers have developed a system designed to identify patients at high risk of discontinuing buprenorphine treatment for opioid use disorder.
Dr. Steven Smith leads National Institutes of Health-funded study to determine minocycline’s potential to address treatment-resistant hypertension
Dr. Steven Smith was awarded $3.3 million by the NIH to study the effects of the antibiotic minocycline on treatment-resistant hypertension.
